Stability of deferoxamine peritoneal dialysate solutions
Kane, M.P.; Bailie, G.R.; Moon, D.G.; Siu, I.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 14(4): 396-398
1994
ISSN/ISBN: 0896-8608 PMID: 7827192 Document Number: 436214
Document emailed within 1 workday
Related Documents
Kane, M.P.; Bailie, G.R.; Moon, D.G.; Siu, I.; Eisele, G. 1994: Stability of erythromycin lactobionate in peritoneal dialysate solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(1): 79-81Paap, C.M.; Nahata, M.C. 1990: Stability of cefotaxime in two peritoneal dialysis solutions American Journal of Hospital Pharmacy 47(1): 147-150
Dooley, D.P.; Tyler, J.R.; Wortham, W.G.; Harrison, L.S.; Starnes, W.F.; Collins, G.R.; Ozuna, I.S.; Violet, P.L.; Ward, J.A. 2003: Prolonged stability of antimicrobial activity in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 58-62
Manley, H.J.; Grabe, D.W.; Norcross, M.; Cooperman, T.A.; Stinchcomb, A.L.; Hass, M.; Bailie, G.R. 2000: Stability of amphotericin B-lipid complex (Abelcet) in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(1): 87-90
Sakurada, T.; Kojima, S.; Oishi, D.; Koitabashi, K.; Miyamoto, M.; Shirai, S.; Shibagaki, Y.; Yasuda, T.; Sato, T.; Kimura, K. 2011: Prothrombin fragment 1 + 2 (F1 + 2) in effluent is a useful marker for peritoneal permeability in peritoneal dialysis patients using neutral dialysate Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 27: 2-5
Krediet, R.T. 2001: Dialysate cancer antigen 125 concentration as marker of peritoneal membrane status in patients treated with chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(6): 560-567
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 1. Stability of some amino acids in solutions Die Pharmazie 27(5): 303-312
Quarto di Palo, F.; Nespoli, A.; Valenti, G.; Miradoli, R.; Polli, E.E. 1978: Recirculated peritoneal dialysate International Journal of Artificial Organs 1(5): 249
Sołowicz, W. 1987: Cytomorphological, cytochemical and functional characteristics of cells from peritoneal dialysate of patients with terminal renal failure treated by intermittent peritoneal dialysis. VI. Functional studies: evaluation of the effect of isolated macrophages on lymphocytes in culture Przeglad Lekarski 44(12): 810-816
Weinreich, T.; Huynh, U.; Zitta, S.; Binder, D.; Gantenbein, H.; Binswanger, U. 1994: Peritoneal dialysate magnesium--how low is safe? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(2): 195-196
Thoma, K.; Struve, M. 1986: The stability of commercial adrenaline solutions. 3. the stability of adrenaline solutions Pharmaceutica Acta Helvetiae 61(3): 66-68
Dharmasena, A.D.; Murphy, S.; Coupe, D.; Coles, G.A. 1993: The influence of dialysate volume on the peritoneal equilibration test Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(2): 164-165
Caravaca, F.; Dominguez, C.; Machado, V.; Arrobas, M. 1993: Vasovagal syncope related to peritoneal dialysate infusion Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(1): 63-64
Whiting, M.A.; Smith, N.I.; Agar, J.W. 1995: Vaginal peritoneal dialysate leakage per fallopian tubes Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(1): 85
Secchi, C.; Martini, E. 1971: Preparation of homogenous growth hormone from peritoneal dialysate Italian Journal of Biochemistry 20(3): 98-111
Pawlaczyk, K.; Garcia-Lopez, E.; Kuzlan-Pawlaczyk, M.; Heimbürger, O.; Bergström, J.; Breborowicz, A.; Lindholm, B. 2001: The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S359-S361
De Santo, N.G.; Capodisaca, G.; Senatore, R.; Cicchetti, T.; Cirillo, D.; Damiano, M.; Giordano, C. 1979: Stability of peritoneal urea clearance in continuous ambulatory peritoneal dialysis (18 months experience with CAPD) International Journal of Artificial Organs 2(4): 193-196
Zhou, F.Q.; Zhou, X.J.; Yu, A.W.; Song, R.H. 1999: Neutrophilic transient acidification and superoxide production in peritoneal dialysate Chinese Medical Sciences Journal 14(4): 215-219
Manley, H.J.; Bridwell, D.L.; Elwell, R.J.; Bailie, G.R. 2003: Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(5): 469-474
Seydel, H.; Voigt, R. 1972: Stability of amino acid infusion solutions. 3. Influence of certain factors on the stability of amino acid infusion solutions Die Pharmazie 27(10): 660-669